Cited by

• Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.

  Levy T, Ben-Rafael Z. Levy T, et al. J Assist Reprod Genet. 1995 Apr;12(4):235-8. doi: 10.1007/BF02212924. J Assist Reprod Genet. 1995. PMID: 7580018 Review. No abstract available.
• Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG.

  Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S. Ben-Rafael Z, et al. J In Vitro Fert Embryo Transf. 1991 Feb;8(1):33-6. doi: 10.1007/BF01131588. J In Vitro Fert Embryo Transf. 1991. PMID: 1826724
• Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.

  Edelstein MC, Brzyski RG, Jones GS, Oehninger S, Sieg SM, Muasher SJ. Edelstein MC, et al. J In Vitro Fert Embryo Transf. 1990 Jun;7(3):172-6. doi: 10.1007/BF01135684. J In Vitro Fert Embryo Transf. 1990. PMID: 2116488
• The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment.

  Dor J, Seidman DS, Ben-Shlomo I, Levran D, Karasik A, Mashiach S. Dor J, et al. J Assist Reprod Genet. 1992 Jun;9(3):228-32. doi: 10.1007/BF01203818. J Assist Reprod Genet. 1992. PMID: 1525451
• Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone.

  Edelstein MC, Brzyski RG, Jones GS, Muasher SJ. Edelstein MC, et al. J In Vitro Fert Embryo Transf. 1990 Oct;7(5):275-9. doi: 10.1007/BF01129534. J In Vitro Fert Embryo Transf. 1990. PMID: 2123917 Clinical Trial.